In some cancers, aberrant activation of JNK1/STAT3 pathways can promote tumor angiogenesis by initiating angiogenesis to facilitate the delivery of oxygen and nutrients to the tumor [241], which can be prevented by compound 3 as an anti-angiogenic agent in Figure 4. This evidence concerns the gene STAT3 and cancer.